BioMedical Engineering OnLine (Nov 2018)

Best serum biomarker combination for ovarian cancer classification

  • Hye-Jeong Song,
  • Eun-Suk Yang,
  • Jong-Dae Kim,
  • Chan-Young Park,
  • Min-Sun Kyung,
  • Yu-Seop Kim

DOI
https://doi.org/10.1186/s12938-018-0581-6
Journal volume & issue
Vol. 17, no. S2
pp. 1 – 7

Abstract

Read online

Abstract Background Screening test using CA-125 is the most common test for detecting ovarian cancer. However, the level of CA-125 is diverse by variable condition other than ovarian cancer. It has led to misdiagnosis of ovarian cancer. Methods In this paper, we explore the 16 serum biomarker for finding alternative biomarker combination to reduce misdiagnosis. For experiment, we use the serum samples that contain 101 cancer and 92 healthy samples. We perform two major tasks: Marker selection and Classification. For optimal marker selection, we use genetic algorithm, random forest, T-test and logistic regression. For classification, we compare linear discriminative analysis, K-nearest neighbor and logistic regression. Results The final results show that the logistic regression gives high performance for both tasks, and HE4-ELISA, PDGF-AA, Prolactin, TTR is the best biomarker combination for detecting ovarian cancer. Conclusions We find the combination which contains TTR and Prolactin gives high performance for cancer detection. Early detection of ovarian cancer can reduce high mortality rates. Finding a combination of multiple biomarkers for diagnostic tests with high sensitivity and specificity is very important.

Keywords